Inventor · disambiguated record
Ronnie Maxwell Lawrence
Also filed as: LAWRENCE RONNIE MAXWELL
14 granted patents·7 pending applications·84 citations·filing 2000–2025
91Inventor score
Files withORPHALAN S A7ACTIMED THERAPEUTICS LTD4KING S COLLEGE LONDON2SMITHKLINE BEECHAM CORP2ANDERTON CLARE LOUISE1
Top patents by PatentIndex Score
21 records- 0194US11117855B2Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical useORPHALAN S A·Filed 2021·Granted Sep 14, 2021·4 cites·27 claims
- 0294US11072577B2Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical useORPHALAN S A·Filed 2021·Granted Jul 27, 2021·6 cites·12 claims
- 0394US10988436B2Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical useORPHALAN S A·Filed 2020·Granted Apr 27, 2021·6 cites·10 claims
- 0489US12358862B2Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical useORPHALAN S A·Filed 2024·Granted Jul 15, 2025·0 cites·14 claims
- 0588US7709677B2Process of preparing arylethanoldiaminesGLAXOSMITHKLINE LLC·Filed 2008·Granted May 4, 2010·14 cites·3 claims
- 0686US12358861B2Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical useORPHALAN S A·Filed 2023·Granted Jul 15, 2025·0 cites·3 claims
- 0786US2025382257A1Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical useORPHALAN S A·Filed 2025·Application pending·0 cites
- 0882US6548523B2Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic propertiesSMITHKLINE BEECHAM CORP·Filed 2000·Granted Apr 15, 2003·17 cites·11 claims
- 0978US8796269B2Crystalline 2-(3,5-Bis(trifluoromethyl)phenyl)-N-(4-(4-fluoro-2-methylphenyl)-6-((7S,9aS)-7-(hydroxymethyl)hexahydropyrazino[2,1-c][1,4]oxazin-8(1H)-yl)pyridin-3-yl)-N,2-dimethyl-propanamide of the formula (I), their use in therapy, and process for the preparation of the sameCRAIG ANDREW SIMON·Filed 2010·Granted Aug 5, 2014·11 cites·9 claims
- 1075US8093242B2Crystalline forms of a pyridine derivativeANDERTON CLARE LOUISE·Filed 2009·Granted Jan 10, 2012·8 cites·9 claims
- 1175US7425639B2ProcessSMITHKLINE BEECHAM CORP·Filed 2001·Granted Sep 16, 2008·15 cites·20 claims
- 1275US2022169594A1Crystalline form of triethylenetetramine tetrahydrochloride and its pharmaceutical useORPHALAN S A·Filed 2021·Application pending·0 cites
- 1370US10870644B2Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-l,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparationKING S COLLEGE LONDON·Filed 2017·Granted Dec 22, 2020·1 cites·14 claims
- 1470US2024423955A1Organic acid addition salts of s-pindololACTIMED THERAPEUTICS LTD·Filed 2024·Application pending·0 cites
- 1566US2025302806A1Organic acid addition salts of s-pindololACTIMED THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
- 1665US7557209B2Process for the preparation of (1S,4R)-cis-4-[2-amino-6-chloro-9H-purin-9-yl]-2-cyclopentene-1-methanolGLAXO GROUP LTD·Filed 2004·Granted Jul 7, 2009·2 cites·9 claims
- 1763US11584741B2Crystalline forms of 4-(5-(4,7-dimethylbenzofuran-2-yl)-1,2,4-oxadiazol-3-yl)benzoic acid and processes for their preparationKING S COLLEGE LONDON·Filed 2020·Granted Feb 21, 2023·0 cites·13 claims
- 1862US12109192B2Organic acid addition salts of S-pindololACTIMED THERAPEUTICS LTD·Filed 2021·Granted Oct 8, 2024·0 cites·11 claims
- 1952US2025320240A1Scalable methods of manufacturing psilocybinCOMPASS PATHFINDER LTD·Filed 2025·Application pending·0 cites
- 2051US2024287074A1Salts and crystalsKinoxis Therapeutics Pty Ltd·Filed 2021·Application pending·0 cites
- 2148US2025228799A1Salt of a pharmaceutical compoundACTIMED THERAPEUTICS LTD·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ronnie Maxwell Lawrence files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →